Real-world data on the efficacy and safety of vedolizumab therapy in patients with inflammatory bowel disease: a retrospective nation-wide cohort study in Singapore

被引：5
|
作者：
Gan, A. T. -M. [1 ]
Chan, W. P. -W. [1 ]
Ling, K. L. [1 ,2 ]
Hartono, L. J. [3 ]
Ong, D. E. [3 ]
Gowans, M. [3 ]
Lin, H. [4 ]
Lim, W. C. [4 ]
Tan, M. T. -K. [5 ]
Ong, J. P. -L. [5 ]
Schwender, B. J. [1 ]
Kong, S. C. [1 ]
Ong, W. C. [1 ]
Lim, T. G. [1 ]
Chuah, S. W. [6 ]
Ooi, C. J. [6 ]
Shim, H. H. [1 ]
机构：
[1] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[2] Mt Elizabeth Hosp, Singapore, Singapore
[3] Natl Univ Singapore Hosp, Div Gastroenterol & Hepatol, Singapore, Singapore
[4] Tan Tock Seng Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[5] Changi Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[6] Gleneagles Hosp, Singapore, Singapore
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.758
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P634
引用
收藏
页码：S434 / S435
页数：2
相关论文
共 50 条
  • [31] Efficacy of Vedolizumab as Induction Therapy for Inflammatory Bowel Disease in a 'real-life' Study
    Trefois, Quentin
    Descamps, Olivier
    Coche, Jean-Charles
    Schapira, Michael
    ACTA CLINICA BELGICA, 2016, 71 : 7 - 7
  • [32] Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel disease
    Judge, Ciaran
    McGettigan, Neasa
    Ryan, Timothy
    Hazel, Karl
    Singh, Pamla
    Parihar, Vikrant
    Stack, Roisin
    O'Connor, Anthony
    Dunne, Cara
    Cullen, Garret
    Egan, Laurence
    Harewood, Gavin
    MacCarthy, Finbar
    McKiernan, Susan
    Mulcahy, Hugh
    Murray, Frank
    Patchett, Stephen
    Sheridan, Juliette
    Cheriyan, Danny
    Farrell, Richard
    Keohane, John
    Kelly, Orlaith
    McNamara, Deirdre
    Ryan, Barbara
    O'Morain, Colm
    Sengupta, Subhasish
    O'Toole, Aoibhlinn
    Buckley, Martin
    McCarthy, Jane
    Doherty, Glen
    Kevans, David
    Slattery, Eoin
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (07) : 786 - 794
  • [33] A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study
    Lenti, Marco Vincenzo
    Levison, Scott
    Eliadou, Elena
    Willert, Robert
    Kemp, Karen
    Carter, Anna
    Stansfield, Catherine
    Assadsangabi, Arash
    Singh, Salil
    Crooks, Ben
    Tattersall, Suzanne
    Fairhurst, Francesca
    Kenneth, Catherine
    Subramanian, Sreedhar
    Probert, Chris
    Storey, Daniel
    Gregg, Belle
    Smith, Paul
    Liu, Eleanor
    Limdi, Jimmy K.
    Johnston, Alex
    Hamlin, Peter John
    Selinger, Christian P.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (12) : 1299 - 1304
  • [34] Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study
    Lin, Wei-Chen
    Tai, Wei-Chen
    Chang, Chung-Hsin
    Tu, Chia-Hung
    Feng, I-Che
    Shieh, Ming-Jium
    Chung, Chen-Shuan
    Yen, Hsu-Heng
    Chou, Jen-Wei
    Wong, Jau-Min
    Liu, Yu-Hwa
    Huang, Tien-Yu
    Chuang, Chiao-Hsiung
    Tsai, Tzung-Jiun
    Chiang, Feng-Fan
    Lu, Chien-Yu
    Hsu, Wen-Hung
    Yu, Fang-Jung
    Chao, Te-Hsin
    Wu, Deng-Chyang
    Ho, Ai-Sheng
    Lin, Hung-Hsin
    Feng, Chun-Lung
    Wu, Keng-Liang
    Wong, Ming-Wun
    Tung, Chien-Chih
    Lin, Chun-Chi
    Chen, Chia-Chang
    Hu, Huang-Ming
    Lu, Lung-Sheng
    Wang, Huann-Sheng
    Wu, I-Chen
    Kuo, Hsin-Yu
    Wu, Jia-Feng
    Yao Shih, Hsiang
    Ni, Yen-Hsuan
    Tang, Shu-Lun
    Chen, Peng-Hsu
    Wei, Shu-Chen
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (11) : 1730 - 1740
  • [35] Colombian real-world experience of vedolizumab use in patients with inflammatory bowel disease-EXVEDOCOL
    Parra Izquierdo, V.
    Cifuentes Amortegui, S.
    Avendano R, S.
    Ponce de Leon, E.
    Florez, C.
    Reyes Medina, G.
    Puentes M, F. E.
    Ballesteros B, M.
    Nunez, E. E.
    Hemandez, M.
    Kock, J.
    Marquez, J. R.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S181 - S182
  • [36] Pregnancy in Inflammatory Bowel Disease: Data from a Real-World Cohort in Germany
    Ayoub, Mousa
    Muzalyova, Anna
    Ebigbo, Alanna
    Nagl, Sandra
    Roemmele, Christoph
    Classen, Johanna
    Wanzl, Julia
    Fleischmann, Carola
    Ayoub, Sami
    Tadic, Vidan
    Schlottmann, Jakob
    Schnoy, Elisabeth
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (24)
  • [37] Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease
    Lamichhane, N.
    Melas, N.
    Bergqvist, V.
    Ekholm, N. -P.
    Olen, O.
    Ludvigsson, J. F.
    Hjortswang, H.
    Marsal, J.
    Eriksson, C.
    Halfvarson, J.
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (06) : 2175 - 2183
  • [38] Real-world experience of vedolizumab use in Colombian patients with inflammatory bowel disease--EXVEDOCOL
    Parra, Viviana
    Cifuentes, Sandra
    Avendano, Sandra
    de Leon, Enrique Ponce
    Florez, Cristian
    Reyes, Gustavo
    Puentes, Fabian
    Ballesteros, Manuel
    Nunez, Edilberto
    Gomez, Federico
    Marquez, Juan Ricardo
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2024, 47 (08): : 858 - 866
  • [39] Effectiveness and safety of thiopurines in inflammatory bowel disease patients with NUDT15 polymorphism: a real-world retrospective study
    Chatterjee, Abhirup
    Bhatia, Prateek
    Sinha, Saroj K.
    Singh, Anupam K.
    Mandavdhare, Harshal S.
    Shah, Jimil
    Jearth, Vaneet
    Sasani, Arpit
    Sekar, Aravind
    Singh, Minu
    Dutta, Usha
    Sharma, Vishal
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2025, 18 (03) : 175 - 183
  • [40] Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study
    Wils, Pauline
    Seksik, Philippe
    Stefanescu, Carmen
    Nancey, Stephane
    Allez, Matthieu
    de Chambrun, Guillaume Pineton
    Altwegg, Romain
    Gilletta, Cyrielle
    Vuitton, Lucine
    Viennot, Stephanie
    Serrero, Melanie
    Fumery, Mathurin
    Savoye, Guillaume
    Collins, Michael
    Goutorbe, Felix
    Brixi, Hedia
    Bouguen, Guillaume
    Tavernier, Noemie
    Boualit, Medina
    Amiot, Aurelien
    Abitbol, Vered
    Laharie, David
    Pariente, Benjamin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (04) : 460 - 470
12345